These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 3484663)

  • 1. Lack of natural killer cell activity in hairy cell leukemia patients and partial restoration with interleukin-2.
    Hooper WC; Barth RF; Shah NT
    Cancer; 1986 Mar; 57(5):988-93. PubMed ID: 3484663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination treatment of 2-chlorodeoxyadenosine and type I interferon on hairy cell leukemia-like cells: cytotoxic effect and MHC-unrestricted killer cell regulation.
    Reiter Z; Tomson S; Ozes ON; Taylor MW
    Blood; 1993 Apr; 81(7):1699-708. PubMed ID: 8096405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe deficiency of natural killer activity in the peripheral blood of patients with hairy cell leukemia.
    Ruco LP; Procopio A; Maccallini V; Calogero A; Uccini S; Annino L; Mandelli F; Baroni CD
    Blood; 1983 Jun; 61(6):1132-7. PubMed ID: 6220750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin 2- and interferon alpha induced natural killer cell activity as a marker of progression in hairy cell leukemia.
    Bigda J; Mysliwska J; Baran W; Hellmann A; Mysliwski A
    Leuk Lymphoma; 1993 Mar; 9(4-5):371-6. PubMed ID: 8348073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms accounting for the defective natural killer activity in patients with hairy cell leukemia.
    Trentin L; Zambello R; Agostini C; Ambrosetti A; Chisesi T; Raimondi R; Bulian P; Pizzolo G; Semenzato G
    Blood; 1990 Apr; 75(7):1525-30. PubMed ID: 2317560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin 12 augments natural killer-cell mediated cytotoxicity in hairy cell leukemia.
    Bigda J; Mysliwska J; Dziadziuszko R; Bigda J; Mysliwski A; Hellmann A
    Leuk Lymphoma; 1993 May; 10(1-2):121-5. PubMed ID: 8104069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural killer lymphocytes in hairy cell leukemia: presence of phenotypically identifiable cells with defective functional activity.
    Smith BR; Rosenthal DS; Ault KA
    Exp Hematol; 1985 Mar; 13(3):189-93. PubMed ID: 3884356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural killer cell function and malignant cell phenotype in hairy cell leukaemia.
    Ogmundsdóttir HM; Thorsteinsson L; Sigfússon A; Sveinsdóttir S; Björnsson S; Eyjólfsson G; Jóhannesson GM; Jensson O
    APMIS; 1992 Jan; 100(1):10-20. PubMed ID: 1536717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased NK activity in hairy cell leukemia (HCL): an analysis at the cellular level.
    Fontana L; De Rossi G; De Sanctis G; Ensoli F; Lopez M; Annino L; Mandelli F
    Blut; 1986 Aug; 53(2):107-13. PubMed ID: 3730622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hairy cell leukemia: absence of natural killer activity and of interleukin 1 release in OKM-1+ spleen hairy cells.
    Ruco LP; Stoppacciaro A; Valtieri M; Procopio A; Uccini S; Baroni CD
    Clin Immunol Immunopathol; 1983 Jan; 26(1):47-55. PubMed ID: 6603305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphocytes from patients with hairy cell leukaemia enable the distinction of two separate subpopulations of activated lymphocyte killer cells generated in mixed lymphocyte culture.
    Werkmeister JA; Boyd AW; Triglia T; Burns GF
    Clin Exp Immunol; 1985 Jul; 61(1):103-8. PubMed ID: 2931219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The beneficial effects of alpha-interferon in hairy cell leukemia are not attributable to NK cell-mediated cytotoxicity.
    Griffiths SD; Cawley JC
    Leukemia; 1987 Apr; 1(4):372-6. PubMed ID: 3669763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Whole blood assay for NK activity in splenectomized and non-splenectomized hairy cell leukemia patients during IFN-alpha-2b treatment.
    Nielsen B; Hokland P; Ellegaard J; Hasselbalch H; Hokland M
    Leuk Res; 1989; 13(6):451-6. PubMed ID: 2770329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural killer cell immunodeficiency in patients with chronic myelogenous leukemia. IV. Interleukin-1 deficiency, gamma-interferon deficiency and the restorative effects of short-term culture in the presence of interleukin-2 on natural killer cytotoxicity, natural killer-target binding and production of natural killer cytotoxic factor.
    Chang WC; Hsiao MH; Pattengale PK
    Nat Immun Cell Growth Regul; 1991; 10(2):57-70. PubMed ID: 1881400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hairy cell leukemia: morphological, cytochemical, immunological and ultrastructural features; and leukopheresis therapy.
    Shih LY; Sung YT
    Taiwan Yi Xue Hui Za Zhi; 1981 Sep; 80(9):961-70. PubMed ID: 6948090
    [No Abstract]   [Full Text] [Related]  

  • 16. Alpha-interferon activated cytotoxic lymphocytes in hairy cell leukemia patients: evaluation of cytotoxic events.
    Trentin L; Ambrosetti A; Zambello R; Agostini C; Masciarelli M; Vinante F; Chilosi M; Pizzolo G; Cetto G; Semenzato G
    Leuk Res; 1987; 11(9):843-7. PubMed ID: 3499539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble interleukin-2 receptors in the sera of patients with hairy cell leukemia: relationship with the effect of recombinant alpha-interferon therapy on clinical parameters and natural killer in vitro activity.
    Chilosi M; Semenzato G; Cetto G; Ambrosetti A; Fiore-Donati L; Perona G; Berton G; Lestani M; Scarpa A; Agostini C
    Blood; 1987 Nov; 70(5):1530-5. PubMed ID: 3117133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunologic and clinical aspects of natural killer cells in human leukemia.
    Lotzová E; Savary CA; Pollock RE; Fuchshuber P
    Nat Immun Cell Growth Regul; 1990; 9(3):173-81. PubMed ID: 2370877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alpha-interferon activates the natural killer system in patients with hairy cell leukemia.
    Semenzato G; Pizzolo G; Agostini C; Ambrosetti A; Zambello R; Trentin L; Luca M; Masciarelli M; Chilosi M; Vinante F
    Blood; 1986 Jul; 68(1):293-6. PubMed ID: 3719101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The abundant NK cells in human secondary lymphoid tissues require activation to express killer cell Ig-like receptors and become cytolytic.
    Ferlazzo G; Thomas D; Lin SL; Goodman K; Morandi B; Muller WA; Moretta A; Münz C
    J Immunol; 2004 Feb; 172(3):1455-62. PubMed ID: 14734722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.